imageplaceholder

PhD in Targets and Therapies
University of Leeds

Student rating
(4.3)

Find out more about studying PhD in Targets and Therapies at University of Leeds? We've gathered all the key details, entry requirements, modules, fees, and more. Take the next step by booking an open day to explore it for yourself.

Different course options

DATA SOURCE:
UNISTATS, UCAS
academic-cap
Qualification

PhD/DPhil - Doctor of Philosophy

academic-cap
Location

Leeds, Main

academic-cap
Study mode

Full Time

academic-cap
Start date

Oct 2026

academic-cap
Duration

3 Year

Jump to

  • -
  • -
  • -

Course info

The programme to develop a new drug starts with a health condition with no suitable medicine, a disease of unmet need. Research aimed at drug discovery starts with the identifying the target, the nucleic acid, protein or signalling pathway that might be activated or inhibited to cause a therapeutic effect. Validation of this target increases confidence that this particular molecule is causative or involved in the disease mechanism. New therapies can then be found through screening for a small molecule or biologic that is effective against that target. Our research focuses on identification and validation of target molecules which then inform the development of small molecule screens and new biologics for use in the clinic.

Tuition fees
Student living
£5,006 per year
Students from Domestic

Accommodation (Self-catered En suite) - Starts £175 Per week

DATA SOURCE:
UCAS / IDP Connect

Uni info

Student rating
(4.3)
View reviews
CUG ranking 21st
University of Leeds
Woodhouse LaneLeedsLS2 9JTUnited Kingdom